Veterinary Medicines

Hydrocortisone aceponate Ecuphar 0.584 mg/ml - Cutaneous spray, solution

Authorised
  • Hydrocortisonaceponat
Download as PDF

Identificación del producto

Nombre del medicamento:
Hydrocortisone aceponate Ecuphar 0.584 mg/ml - Cutaneous spray, solution
Principio activo:
Especies de destino:
  • Perros
Vía de administración:
  • Uso cutáneo

Datos del producto

Principio activo y concentración:
  • Disponible únicamente en English
    0.58
    Miligramo(s)
    /
    1.00
    Frasco
Forma farmacéutica:
  • Solución para pulverización cutánea
Withdrawal period by route of administration:
  • Cutaneous use
    • Perros
Código Anatómico Terapéutico Químico Veterinario (ATCvet):
  • QD07AC
Régimen jurídico de dispensación:
Estado de la autorización:
  • Autorizado
Authorised in:
  • Alemania
  • Austria
  • Bulgaria
  • Bélgica
  • Chipre
  • Croacia
  • Dinamarca
  • Eslovaquia
  • Eslovenia
  • España
  • Estonia
  • Finlandia
  • Francia
  • Grecia
  • Hungría
  • Irlanda
  • Islandia
  • Italia
  • Letonia
  • Liechtenstein
  • Lituania
  • Luxemburgo
  • Malta
  • Noruega
  • Países Bajos
  • Polonia
  • Portugal
  • República Checa
  • Rumania; Rumanía
  • Suecia
  • United Kingdom (Northern Ireland)
Descripción del empaquetado:

Información adicional

Entitlement type:
Fundamento jurídico de la autorización del producto:
Titular de la autorización de comercialización:
  • Ecuphar
Autorización de comercialización expedida:
Centros de fabricación responsables de la liberación del lote:
  • Divasa Farmavic S.A.
País de la autorización:
No se dispone de esta información para este producto.
Autoridad responsable:
  • European Commission
Número de autorización:
No se dispone de esta información para este producto.
Fecha del cambio de estado de la autorización:

Documentos

Combined File of all Documents

Published:
Bulgarian (PDF)
Download

Combined File of all Documents

Published:
Czech (PDF)
Download

Combined File of all Documents

Published:
Danish (PDF)
Download

Combined File of all Documents

Published:
German (PDF)
Download

Combined File of all Documents

Published:
Greek (PDF)
Download

Combined File of all Documents

Published:
Español (PDF)
Download

Combined File of all Documents

Published:
Estonian (PDF)
Download

Combined File of all Documents

Published:
Finnish (PDF)
Download

Combined File of all Documents

Published:
French (PDF)
Download

Combined File of all Documents

Published:
Croatian (PDF)
Download

Combined File of all Documents

Published:
Hungarian (PDF)
Download

Combined File of all Documents

Published:
Icelandic (PDF)
Download

Combined File of all Documents

Published:
Italian (PDF)
Download

Combined File of all Documents

Published:
Lithuanian (PDF)
Download

Combined File of all Documents

Published:
Latvian (PDF)
Download

Combined File of all Documents

Published:
Maltese (PDF)
Download

Combined File of all Documents

Published:
Dutch (PDF)
Download

Combined File of all Documents

Published:
Norwegian (PDF)
Download

Combined File of all Documents

Published:
Polish (PDF)
Download

Combined File of all Documents

Published:
Portuguese (PDF)
Download

Combined File of all Documents

Published:
Romanian (PDF)
Download

Combined File of all Documents

Published:
Slovak (PDF)
Download

Combined File of all Documents

Published:
Slovenian (PDF)
Download

Combined File of all Documents

Published:
Swedish (PDF)
Download

Combined File of all Documents

Published:
English (PDF)
Download

ema-puar-hydrocortisone-aceponate-ecuphar-v-4689-par-en.pdf

Published:
English (PDF)
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."